Classes
Publications
- PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Monoclonal antibodies in the treatment of dyslipidemia and cardiovascular risk lowering2016 | First Faculty of Medicine
- Plant sterols and stanols: not yet own recommendations for diet enrichment targeted reduction of LDL - cholesterol and cardiovascular risk2015 | First Faculty of Medicine
- Addison disease2012 | First Faculty of Medicine
- Acromegaly2012 | First Faculty of Medicine
- Hyperlipoproteinaemia and dyslipidaemia in the elderly2012 | First Faculty of Medicine
- Dyslipidemia in 20122012 | First Faculty of Medicine
- Pharmacotherapy of dyslipidaemia – physicians´ guide2012 | First Faculty of Medicine
- Fixed combinaton of choice for the treatment of hypertension and cardiovascular disease2012 | First Faculty of Medicine
- Choosing treatment strategy - basic prerequisite for successful prevention of cardiovascular events2012 | First Faculty of Medicine
Loading network view...